These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 8887274

  • 1. Advanced glycation end products modulate transcriptional regulation in mesangial cells.
    Iehara N, Takeoka H, Yamada Y, Kita T, Doi T.
    Kidney Int; 1996 Oct; 50(4):1166-72. PubMed ID: 8887274
    [Abstract] [Full Text] [Related]

  • 2. Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism.
    Pugliese G, Pricci F, Romeo G, Pugliese F, Mené P, Giannini S, Cresci B, Galli G, Rotella CM, Vlassara H, Di Mario U.
    Diabetes; 1997 Nov; 46(11):1881-7. PubMed ID: 9356040
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of Advanced Glycation End Products (AGEs) Accumulation by Pyridoxamine Modulates Glomerular and Mesangial Cell Estrogen Receptor α Expression in Aged Female Mice.
    Pereira-Simon S, Rubio GA, Xia X, Cai W, Choi R, Striker GE, Elliot SJ.
    PLoS One; 2016 Nov; 11(7):e0159666. PubMed ID: 27428057
    [Abstract] [Full Text] [Related]

  • 4. Mitofusin 2 attenuates the histone acetylation at collagen IV promoter in diabetic nephropathy.
    Mi X, Tang W, Chen X, Liu F, Tang X.
    J Mol Endocrinol; 2016 Nov; 57(4):233-249. PubMed ID: 27997345
    [Abstract] [Full Text] [Related]

  • 5. Administration of AGEs in vivo induces extracellular matrix gene expression.
    Striker LJ, Striker GE.
    Nephrol Dial Transplant; 1996 Nov; 11 Suppl 5():62-5. PubMed ID: 9044310
    [Abstract] [Full Text] [Related]

  • 6. Advanced glycation end products regulate extracellular matrix protein and protease expression by human glomerular mesangial cells.
    Berrou J, Tostivint I, Verrecchia F, Berthier C, Boulanger E, Mauviel A, Marti HP, Wautier MP, Wautier JL, Rondeau E, Hertig A.
    Int J Mol Med; 2009 Apr; 23(4):513-20. PubMed ID: 19288028
    [Abstract] [Full Text] [Related]

  • 7. Chrysin Inhibits Advanced Glycation End Products-Induced Kidney Fibrosis in Renal Mesangial Cells and Diabetic Kidneys.
    Lee EJ, Kang MK, Kim DY, Kim YH, Oh H, Kang YH.
    Nutrients; 2018 Jul 09; 10(7):. PubMed ID: 29987200
    [Abstract] [Full Text] [Related]

  • 8. Type IV collagen is transcriptionally regulated by Smad1 under advanced glycation end product (AGE) stimulation.
    Abe H, Matsubara T, Iehara N, Nagai K, Takahashi T, Arai H, Kita T, Doi T.
    J Biol Chem; 2004 Apr 02; 279(14):14201-6. PubMed ID: 14732718
    [Abstract] [Full Text] [Related]

  • 9. Albumin modified by Amadori glucose adducts activates mesangial cell type IV collagen gene transcription.
    Cohen MP, Hud E, Wu VY, Ziyadeh FN.
    Mol Cell Biochem; 1995 Oct 04; 151(1):61-7. PubMed ID: 8584015
    [Abstract] [Full Text] [Related]

  • 10. Role of intron 1 in smooth muscle alpha-actin transcriptional regulation in activated mesangial cells in vivo.
    Kawada N, Moriyama T, Ando A, Koyama T, Hori M, Miwa T, Imai E.
    Kidney Int; 1999 Jun 04; 55(6):2338-48. PubMed ID: 10354281
    [Abstract] [Full Text] [Related]

  • 11. Interaction between the polyol pathway and non-enzymatic glycation on mesangial cell gene expression.
    Dan Q, Wong RL, Yin S, Chung SK, Chung SS, Lam KS.
    Nephron Exp Nephrol; 2004 Jun 04; 98(3):e89-99. PubMed ID: 15528949
    [Abstract] [Full Text] [Related]

  • 12. Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease.
    Yang CW, Vlassara H, Peten EP, He CJ, Striker GE, Striker LJ.
    Proc Natl Acad Sci U S A; 1994 Sep 27; 91(20):9436-40. PubMed ID: 7937785
    [Abstract] [Full Text] [Related]

  • 13. Transcriptional activation of the alpha1(I) procollagen gene and up-regulation of alpha1(I) and alpha1(III) procollagen messenger RNA in dermal fibroblasts from tight skin 2 mice.
    Christner PJ, Hitraya EG, Peters J, McGrath R, Jiménez SA.
    Arthritis Rheum; 1998 Dec 27; 41(12):2132-42. PubMed ID: 9870870
    [Abstract] [Full Text] [Related]

  • 14. Ribozyme targeting of receptor for advanced glycation end products in mouse mesangial cells.
    Tsuji H, Iehara N, Masegi T, Imura M, Ohkawa J, Arai H, Ishii K, Kita T, Doi T.
    Biochem Biophys Res Commun; 1998 Apr 17; 245(2):583-8. PubMed ID: 9571198
    [Abstract] [Full Text] [Related]

  • 15. PDGF and TGF-beta mediate collagen production by mesangial cells exposed to advanced glycosylation end products.
    Throckmorton DC, Brogden AP, Min B, Rasmussen H, Kashgarian M.
    Kidney Int; 1995 Jul 17; 48(1):111-7. PubMed ID: 7564067
    [Abstract] [Full Text] [Related]

  • 16. Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor.
    Doi T, Vlassara H, Kirstein M, Yamada Y, Striker GE, Striker LJ.
    Proc Natl Acad Sci U S A; 1992 Apr 01; 89(7):2873-7. PubMed ID: 1313571
    [Abstract] [Full Text] [Related]

  • 17. Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells.
    Huang K, Huang J, Xie X, Wang S, Chen C, Shen X, Liu P, Huang H.
    Free Radic Biol Med; 2013 Dec 01; 65():528-540. PubMed ID: 23891678
    [Abstract] [Full Text] [Related]

  • 18. Rosiglitazone prevents advanced glycation end products-induced renal toxicity likely through suppression of plasminogen activator inhibitor-1.
    Yu X, Li C, Li X, Cai L.
    Toxicol Sci; 2007 Apr 01; 96(2):346-56. PubMed ID: 17264099
    [Abstract] [Full Text] [Related]

  • 19. Three-dimensional matrix primes mesangial cells to down-regulation of alpha-smooth muscle actin via deactivation of CArG box elements.
    Kitamura M, Ishikawa Y.
    Kidney Int; 1998 Mar 01; 53(3):690-7. PubMed ID: 9507215
    [Abstract] [Full Text] [Related]

  • 20. Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor-β1 RAGE.
    Serban AI, Stanca L, Geicu OI, Munteanu MC, Costache M, Dinischiotu A.
    J Diabetes; 2015 Jan 01; 7(1):114-24. PubMed ID: 24666836
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.